Palo Alto, CA, United States of America

James Anthony Byrne

USPTO Granted Patents = 5 

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • St. Petersburg, FL (US) (2011)
  • Santa Monica, CA (US) (2014)
  • Palo Alto, CA (US) (2011 - 2019)

Company Filing History:


Years Active: 2011-2019

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of James Anthony Byrne

Introduction

James Anthony Byrne is a notable inventor based in Palo Alto, CA. He has made significant contributions to the field of biotechnology, particularly in the development of pluripotent cell lines. With a total of 5 patents to his name, Byrne's work has the potential to impact various areas of medical research and treatment.

Latest Patents

Byrne's latest patents focus on methods of generating cell lines with sequence variation or copy number variation of a gene of interest. These patents provide innovative methods and applications for creating pluripotent cell lines, which are crucial for advancing research in regenerative medicine and genetic studies.

Career Highlights

Throughout his career, James Anthony Byrne has worked with prestigious institutions such as Leland Stanford Junior University and the Parkinson's Institute. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Byrne has collaborated with notable colleagues, including Renee Ann Reijo Pera and J William Langston. These partnerships have further enhanced his research and innovation in the field of biotechnology.

Conclusion

James Anthony Byrne's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical research and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…